135 related articles for article (PubMed ID: 20423313)
1. Statistical molecular design of balanced compound libraries for QSAR modeling.
Linusson A; Elofsson M; Andersson IE; Dahlgren MK
Curr Med Chem; 2010; 17(19):2001-16. PubMed ID: 20423313
[TBL] [Abstract][Full Text] [Related]
2. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.
Roy K; Mitra I
Comb Chem High Throughput Screen; 2011 Jul; 14(6):450-74. PubMed ID: 21521150
[TBL] [Abstract][Full Text] [Related]
3. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
Ebalunode JO; Zheng W; Tropsha A
Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
[TBL] [Abstract][Full Text] [Related]
4. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
Tropsha A; Golbraikh A
Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
[TBL] [Abstract][Full Text] [Related]
5. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
[TBL] [Abstract][Full Text] [Related]
6. Descriptors and their selection methods in QSAR analysis: paradigm for drug design.
Danishuddin ; Khan AU
Drug Discov Today; 2016 Aug; 21(8):1291-302. PubMed ID: 27326911
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR in drug design--a review.
Verma J; Khedkar VM; Coutinho EC
Curr Top Med Chem; 2010; 10(1):95-115. PubMed ID: 19929826
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary computation and QSAR research.
Aguiar-Pulido V; Gestal M; Cruz-Monteagudo M; Rabuñal JR; Dorado J; Munteanu CR
Curr Comput Aided Drug Des; 2013 Jun; 9(2):206-25. PubMed ID: 23700999
[TBL] [Abstract][Full Text] [Related]
9. QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.
Pan J; Zhang Y; Ran T; Xu A; Qiao X; Yin L; Zhou W; Zhu L; Zhao J; Lu T; Chen Y; Jiang Y
Mol Divers; 2017 Aug; 21(3):719-739. PubMed ID: 28689235
[TBL] [Abstract][Full Text] [Related]
10. Focus-2D: a new approach to the design of targeted combinatorial chemical libraries.
Cho SJ; Zheng W; Tropsha A
Pac Symp Biocomput; 1998; ():305-16. PubMed ID: 9697191
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship models for compounds with anticonvulsant activity.
Bellera CL; Talevi A
Expert Opin Drug Discov; 2019 Jul; 14(7):653-665. PubMed ID: 31072145
[No Abstract] [Full Text] [Related]
12. Statistical molecular design: a tool to follow up hits from small-molecule screening.
Lindgren AE; Larsson A; Linusson A; Elofsson M
Methods Mol Biol; 2014; 1056():169-88. PubMed ID: 24306873
[TBL] [Abstract][Full Text] [Related]
13. Identification of Bioactive Scaffolds Based on QSAR Models.
Nakagawa T; Miyao T; Funatsu K
Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29135084
[TBL] [Abstract][Full Text] [Related]
14. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
[TBL] [Abstract][Full Text] [Related]
15. QSAR modeling of imbalanced high-throughput screening data in PubChem.
Zakharov AV; Peach ML; Sitzmann M; Nicklaus MC
J Chem Inf Model; 2014 Mar; 54(3):705-12. PubMed ID: 24524735
[TBL] [Abstract][Full Text] [Related]
16. In-Silico Extraction of Design Ideas Using MMPA-by-QSAR and its Application on ADME Endpoints.
Koutsoukas A; Chang G; Keefer CE
J Chem Inf Model; 2019 Jan; 59(1):477-485. PubMed ID: 30497262
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening.
Ballante F; Caroli A; Wickersham RB; Ragno R
J Chem Inf Model; 2014 Mar; 54(3):956-69. PubMed ID: 24564321
[TBL] [Abstract][Full Text] [Related]
18. Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase.
Xing L; Goulet R; Johnson K
J Chem Inf Model; 2011 Jul; 51(7):1582-92. PubMed ID: 21615155
[TBL] [Abstract][Full Text] [Related]
19. Multi-objective Optimization of Benzamide Derivatives as Rho Kinase Inhibitors.
Cardoso Gajo G; Rodrigues Silva D; Barigye SJ; da Cunha EFF
Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28876533
[TBL] [Abstract][Full Text] [Related]
20. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
